Medical technology company BioNexus Gene Lab Corp. (NASDAQ:BGLC) announced the adoption of Ethereum (CRYPTO: ETH) as ...

The tech firm will prioritize Ethereum over Bitcoin as a strategic asset, touting the asset's potential as a "financial ...

BioNexus Gene Lab (BGLC) announced a strategic partnership with ML Tech to optimize the BGLC’s Ethereum-based growth ...

BioNexus Gene Lab Corporation, a leading medical laboratory services provider, has made history by becoming the first ...

BioNexus Gene Lab board of directors has officially approved the Ethereum-focused treasury strategy, alongside an ETH ...

KUALA LUMPUR, Malaysia, March 08, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a ...

To provide transparency and further insight into this decision, BGLC has published its Ethereum Strategy Whitepaper, which is now available to the public. This document outlines Ethereum’s role as a ...

KUALA LUMPUR, Malaysia, March 08, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a ...

Ethereum has been chosen over Bitcoin as a medical firm's treasury asset. The firm cited staking, DeFi, dApps, and other ...